Dr. Emerson Perin, MD

• Cardiology

• Interventional Cardiology

• Clinical Research

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Interventional Cardiology From Texas Heart Institute At The St. Lukes Hospital

  Fellowship Hospital

• Jackson Memorial Hospital, University Of Miami Medical Hospital - Miami Fl

  Internship Hospital

• Interventional Cardiology From Texas Heart Institute At The St. Lukes Hospital|texas Heart Institute

  Fellowship Hospital, 1991

• Texas Heart Institute

  Fellowship Hospital, 1991

• Jackson Memorial Hospital

  Residency Hospital, 1988

• Universidade Federal Do Rio Grande Do Sul, Faculdade De Medicina

  Medical School, 1983

• English

• Portuguese

• Spanish

• A Detailed Analysis of Bone Marrow from Patients with Ischemic Heart Disease and Left Ventricular Dysfunction: BM CD34, CD11b and Clonogenic Capacity as Biomarkers for Clinical Outcomes, 2014-08-18

• Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients The CCTRN SENECA Trial, 2020-12-22

• Bone Marrow Cell Characteristics Associated with Patient Profile and Cardiac Performance Outcomes in the LateTIME-CCTRN Trial, 2016-07-06

• Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial?, 2018-04-04

• A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial, 2021-04-13

• Rationale and Design for PACE: P atients with Intermittent Claudication Injected with A LDH Bright Ce lls, 2014-07-30

• Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials, 2016-11-23

• Baseline Assessment and Comparison of Arterial Anatomy, Hyperemic Flow and Skeletal Muscle Perfusion in Peripheral Artery Disease: The CCTRN PACE Study, 2016-10-02

• A Critical Analysis of Clinical Outcomes Reported in Stem Cell Trials for Acute Myocardial Infarction: Some Thoughts for Design of Future Trials, 2013-07-19

• Gene therapy knockdown of Hippo signaling induces cardiomyocyte renewal in pigs after myocardial infarction, 2021-06-30

• Peripheral Blood Biomarkers Associated With Improved Functional Outcome in Patients With Chronic Left Ventricular Dysfunction: A Biorepository Evaluation of the FOCUS-CCTRN Trial, 2021-09-03

• The TIME Trial - Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis, 2017-12-05

• The Use of Gadolinium-Carbon Nanostructures to Magnetically Enhance Stem Cell Retention for Cellular Cardiomyoplasty, 2013-10-20

• Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial, 2015-11-19

• Rationale and Design of the CONCERT-HF ( C ombination O f mese N chymal and c-kit+ C ardiac st E m cells as R egenerative T herapy for H eart F ailure) Trial, 2018-04-27

• Bone Marrow Characteristics Associated with Changes in Infarct Size after STEMI: A Biorepository Evaluation from the CCTRN TIME Trial, 2014-11-18

• Effect of Intracoronary Delivery of Autolologous Bone Marrow Mononuclear Cells Two to Three Weeks Following Acute Myocardial Infarction on Left-Ventricular Function: The LateTIME Randomized Trial, 2011-11-14

• Bismuth@US-tubes as a Potential Contrast Agent for X-ray Imaging Applications, 2013-10-07

• Implementation of Cardiovascular Cell Therapy Network TrialsChallenges, Innovation, andLessons Learned:Experiences of the CCTRN, 2013-10-23

• Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN P atients with Intermittent Claudication Injected with A LDH Bright Ce lls (PACE) Trial, 2017-02-16

• Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Ischemic Heart Failure: The FOCUS-CCTRN Trial, 2012-03-24

• Labeling Stem Cells with a New Hybrid Bismuth/Carbon Nanotube Contrast Agent for X-Ray Imaging, 2019-06-11

• Gadonanotubes as Magnetic Nanolabels for Stem Cell Detection, 2010-10-20

• Imaging Long-Term Fate of Intramyocardially Implanted Mesenchymal Stem Cells in a Porcine Myocardial Infarction Model, 2011-09-01

• Rationale and Design for TIME: A Phase-II, Randomized, Double-Blind, Placebo-Controlled Pilot Trial Evaluating the Safety and Effect of Timing of Administration of Bone Marrow Mononuclear Cells Following Acute Myocardial Infarction, 2009-07-23

• Synthesis and Evaluation of an Anti-MLC1 × Anti-CD90 Bispecific Antibody for Targeting and Retaining Bone-Marrow Derived Multipotent Stromal Cells in Infarcted Myocardium, 2011-08-02

• A New High-Performance Gadonanotube-Polymer Hybrid Material for Stem Cell Labeling and Tracking by MRI, 2018-07-10

• Direct Stimulation of Cardiogenesis: A New Paradigm for Treating Heart Disease, 2017-06-23

• Phase II Clinical Research Design in Cardiology Learning the Right Lessons Too Well: Observations and Recommendations From the Cardiovascular Cell Therapy Research Network (CCTRN), 2013-04-16

• Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction: The TIME Randomized Trial, 2012-12-12

• Rare delayed cardiac tamponade in a pig after cardiac surgery, 2022-08-03

• Reproducibility of cuff-induced hyperemic popliteal artery flow analysis using phase-contrast MRI: Patients With Intermittent Claudication Injected With ALDH Bright Cells (PACE) trial, 2016-01-27